Boehringer Ingelheim
@boehringerus
Followers
66K
Following
383
Statuses
6K
Join the conversation on the latest news from Boehringer Ingelheim in the U.S.
Ridgefield, CT
Joined July 2009
#NEWS — We are proud to announce that our pivotal Phase III FIBRONEER-ILD study met its primary endpoint. Learn more:
0
3
6
#NEWS: We’re pleased to collaborate with @GuardantHealth to develop a companion diagnostic for patients with HER2-mutated NSCLC. Learn more below. #LifeForward
Today, we announced a collaboration with @BoehringerUS to pursue the regulatory approval of our Guardant360® CDx liquid biopsy as a companion diagnostic to Boehringer’s investigational #LungCancer therapy. Partnership details:
0
1
7
#NEWS: We presented data on our targeted cancer therapy candidate in patients with previously treated HER2 mutated lung cancer at #ESMOASIA24. Learn more: #LungCancer #OncologyResearch
0
0
1
#NEWS – We’re excited to announce U.S. FDA Breakthrough Therapy designation for our investigational treatment for adults living with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced fibrosis. Learn more: #LifeForward
0
4
6
#NEWS — We are excited to announce that our pivotal Phase III FIBRONEER-IPF study met its primary endpoint. Learn more:
0
2
7
@Mygreatredmare @Boehringer @TheBridgeSanct1 Hi! Thank you for reaching out. If you could kindly visit our website to share this request, a member of our team will be in touch to follow-up. We look forward to hearing from you. Thanks!
1
1
1
@risk__reward Hello - Thank you for your message about Vetmedin quantities. Our Veterinary Technical Solutions team has been made aware of your inquiry and is available to help you with this question. You can contact them at 1-888-637-4251. We look forward to hearing from you. Thank you!
0
0
0
#NEWS – We’re proud to now offer our #biosimilar at a low cash price through an exclusive partnership with @GoodRx. Find out more:
1
2
2
@pictureNC @DNC @GOP Thanks for your message. We have multiple different patient assistance programs. More information is available through our Boehringer Cares Foundation at or by phone via 800-556-8317. Reps are available Mon–Fri; 7:30am–5:00pm CST.
0
0
0
#NEWS—Better animal health means expanding opportunities for future veterinary professionals. It’s why we’re announcing a new scholarship fund with @TuskegeeUniv to support diversity in veterinary medicine education and training. Learn more:
0
2
5
#NEWS – We are thrilled to announce our full Phase II data results for adults living with #MASH and liver fibrosis F1, F2 and F3 were presented at the @EASLnews congress today. Learn more: #EASLCongress #LifeForward
0
0
7
#NEWS – We’re excited to expand access to our biosimilar through a private-label agreement. Learn more:
3
2
2
#NEWS: We are proud to announce our new collaboration with @Walgreens and @EmVenioResearch to improve diversity and access in clinical trials. Learn more:
1
1
6
#NEWS – We’re proud to share that the FDA has approved an additional formulation of our biosimilar for patients living with certain chronic inflammatory diseases. Learn more:
2
3
7
#NEWS: Our new program caps out-of-pocket costs at $35 per month for eligible patients for all of our inhaler products. Learn more:
0
2
7
RT @Boehringer: #NEWS: We are continuing our successful collaboration with 3T Biosciences to develop more novel cancer immunotherapies for…
0
3
0